Charitable Contributions in 2019

Posted:
2
January 2020

As the 2019 year comes to an end, we would like to recognize the substantial charitable contributions made by the Richmond Pharmacology team; including our staff, academic

As the 2019 year comes to an end, we would like to recognize the substantial charitable contributions made by the Richmond Pharmacology team; including our staff, academic partners, collaborators and volunteers.Various initiatives have been undertaken including homeless sleep outs, bake sales, marathon events and Christmas Jumper day; all to raise money for those less fortunate than ourselves.

We would like to personally thank two very special volunteers, who decided to donate the payment they received from their study participants to the British Heart Foundation.At Richmond Pharmacology, our ethos is to improve the standard of living for millions of people through our research.

It is through generous donations, initiatives, and partnerships like these, that we are able to achieve our mission.

Notable donations throughout the year have been made to the following Charities

Looking to next year, 2020 promises to be another exciting year for Richmond Pharmacology and we look forward to continuing our charitable endeavors.Read letter of thanks from Robes

Latest news

Upcoming Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

21 - 23 September 2020
Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.
View event

Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics

October 20, 2020
Phase I study of Intellia Therapeutic’s NTLA-2001 for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN)
Read more

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 17, 2020
Richmond Pharmacology early phase drug development update.
Read more